BPC-157: A Review of Current In-Vitro Research

BPC-157 is a 15-amino acid peptide with a molecular weight of 1419.53 g/mol and the molecular formula C₆₂H₉₈N₁₆O₂₂. It is produced synthetically via solid-phase peptide synthesis and is available in lyophilised powder form for laboratory use. It is not approved for human use by any regulatory authority and is sold exclusively for in-vitro research purposes.

In-vitro studies involving BPC-157 have examined several areas of cell biology. Researchers have investigated the peptide's interactions with fibroblast cell lines, its behaviour in musculoskeletal cell signalling models, and its effects on nitric oxide system activity in isolated cell preparations.

Studies published in peer-reviewed journals have examined BPC-157 in the context of:

• Tendon and ligament fibroblast cell cultures
• Gastrointestinal epithelial cell models
• Endothelial cell signalling pathways
• Nitric oxide modulation in isolated tissue preparations

For reliable in-vitro results, peptide purity is critical. Researchers should source BPC-157 with a minimum HPLC-verified purity of ≥98%, accompanied by a certificate of analysis (CoA) for each lot. The compound should be stored at −20°C in a desiccated environment away from light. Reconstitution should be performed using bacteriostatic water under sterile conditions appropriate to the research setting.

It is important to note that in-vitro findings do not directly translate to in-vivo or clinical outcomes. Laboratory results represent early-stage mechanistic investigation only.